MedTrace Logo

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection

NCT02512939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 675

Last updated 2023-05-16

No results posted yet for this study

Summary

This study will assess the next generation of blood tests for latent TB infection, which may be able to indicate how treatment is working as well as in diagnosis infection.

Conditions

Interventions

PROCEDURE

blood test, not yet marketed, no trade name

blood test using the new TB diagnostic test

Sponsors & Collaborators

  • Public Health England

    collaborator OTHER_GOV

  • University College, London

    lead OTHER

Principal Investigators

  • Ibrahim Abubakar, PhD · University College, London

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02512939 on ClinicalTrials.gov